Thorneloe, Kevin S.
Sepp, Armin
Zhang, Sean
Galinanes-Garcia, Laura
Galette, Paul
Al-Azzam, Wasfi
Vugts, Danielle J.
van Dongen, Guus
Elsinga, Phillip
Wiegers, Johan
Glaudemans, Andor W. J. M.
Vincent, Veena
Renaux, Jessica
Szapacs, Matt
Birchler, Mary
Cleveland, Matthew
Bergstrom, Mats
Davies, Marie http://orcid.org/0000-0002-0821-4236
Funding for this research was provided by:
GlaxoSmithKline
Article History
Received: 17 January 2019
Accepted: 23 April 2019
First Online: 21 May 2019
Ethics approval and consent to participate
: This article does not contain any studies with animals performed by any of the authors. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: All authors provided written consent for publication.
: KT, AS, PG, WA, VV, MS, MBi, MC, and MD are employee and shareholders of GSK. SZ, LGC, and JR were employees of GSK at the time the study was conducted. MBe was an external consultant to GSK. No conflict of interest for DV, GvD, PE, JW, and AG.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.